Literature DB >> 35108577

Genome analysis suggests HTLV-1aA introduction in Chile related to migrations of ancestral indigenous populations.

Louise Zanella1, Ismael Riquelme2, Maria Elena Reyes3, Francisca Infante4, Soledad Reyes5, Eugenio Ramirez6, Carmen Ili7, Priscilla Brebi8.   

Abstract

The human T cell lymphotropic virus type 1 (HTLV-1), unlike other RNA viruses such as HIV, has a stable genome and has infected humans since remote times. Although the HTLV-1 infection is endemic in South America, there is scarce information about HTLV-1 in Chile and its history of introduction. This study assessed the genomic content of HTLV-1 from Chile and its relationship with HTLV-1 lineages circulating worldwide by phylogenetic reconstruction and dating analyses. A total of 30 HTLV-1 genomes collected from the four continents were used to conduct dating analyses, including the first HTLV-1 genome from Amerindian/Mapuche ethnicity. Estimation was performed using a Bayesian Markov Chain Monte Carlo coalescent-based approach as implemented in the BEAST program. The time of the most recent ancestor of HTLV-1 from Chile was ∼1409 years ago, which coincides with the period of Amerindian population expansion across South America. Our results suggest HTLV-1aA was possibly introduced in Chile during the migrations of the ancestral indigenous populations.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chile; Genome dating analysis; Human T-cell lymphotropic virus (HTLV); ancestral migrations

Mesh:

Year:  2022        PMID: 35108577     DOI: 10.1016/j.virusres.2022.198687

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  1 in total

1.  HTLV infection in Brazil's second-largest indigenous reserve.

Authors:  Carolina Amianti; Larissa Melo Bandeira; Gabriela Alves Cesar; Sabrina Weis-Torres; Tayana Serpa Ortiz Tanaka; Indianara Ramires Machado; Crhistinne Cavalheiro Maymone Gonçalves; Simone Simionatto; Erica Cristina Dos Santos Schnaufer; Felipe Bonfim Freitas; Antonio Carlos Rosário Vallinoto; Julio Croda; Ana Rita Coimbra Motta-Castro
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.